Bisphosphonate use, oral flora, saliva, gingival crevicular fluid and bone markers in patients with jaw osteonecrosis
Bisphosphonate use, oral flora, saliva, gingival crevicular fluid and bone markers in patients with jaw osteonecrosis
批准号:
nhmrc : 520172
负责人:
Dr Claudine Tsao
金额:
$8.12万
依托单位国家:
澳大利亚
项目类别:
NHMRC Postgraduate Scholarships
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2012-12-31
中文摘要
双膦酸盐用于骨质疏松症等骨质容易断裂的患者。最近的研究表明,这些药物和颌骨断裂之间可能存在联系,称为颌骨坏死-一种目前没有有效治疗的破坏性疾病。目前还不清楚为什么这种情况只影响颌骨。这项研究旨在调查口腔中的细菌、牙龈疾病和唾液是否与颌骨骨坏死有关,这有助于改善治疗。
英文摘要
Bisphosphonates are used in patients with bones that break easily due to conditions such as osteoporosis. Recent research suggests a possible association between these drugs and jaw bone breakdown called jaw osteonecrosis - a devastating condition with no current effective treatment. It is unclear why this condition affects only jaw bones. This study seeks to investigate if bacteria in the mouth, gum disease and saliva are involved in jaw osteonecrosis, which can then help to improve management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
降低慢病毒载体转录“通读率”的研究
-
批准号:81271690
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张敬之
-
依托单位: